231
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Treatment Costs for Patients with Chronic Kidney Disease Who Received Multidisciplinary Care in a District Hospital in Thailand

ORCID Icon, ORCID Icon & ORCID Icon
Pages 223-231 | Published online: 28 Apr 2020

References

  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
  • Ingsathit A, Thakkinstian A, Chaiprasert A, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: thai SEEK study. Nephrol Dial Transplant. 2010;25(5):1567–1575. doi:10.1093/ndt/gfp669
  • Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74(1):120–131. doi:10.1053/j.ajkd.2018.12.044
  • Kaewput W, Thongprayoon C, Chewcharat A, et al. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: a nationwide retrospective cohort study. Ther Apher Dial. 2020. doi:10.1111/1744-9987.13480
  • Manns B, Hemmelgarn B, Tonelli M, et al. The cost of care for people with chronic kidney disease. Can J Kidney Health Dis. 2019;6:2054358119835521. doi:10.1177/2054358119835521
  • Chen YR, Yang Y, Wang SC, et al. Multidisciplinary care improves clinical outcome and reduces medical costs for pre-end-stage renal disease in Taiwan. Nephrology (Carlton). 2014;19(11):699–707. doi:10.1111/nep.12316
  • Lin E, Chertow GM, Yan B, Malcolm E, Goldhaber-Fiebert JD, Taal MW. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: a modeling study. PLoS Med. 2018;15(3):e1002532. doi:10.1371/journal.pmed.1002532
  • Saran R, Robinson B, Abbott KC, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1S1):A6–A7. doi:10.1053/j.ajkd.2019.09.003
  • Moreno Velasquez I, Tribaldos Causadias M, Valdes R, et al. End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study. BMJ Open. 2019;9(5):e027229. doi:10.1136/bmjopen-2018-027229
  • Eriksson JK, Neovius M, Jacobson SH, Elinder CG, Hylander B. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden. BMJ Open. 2016;6(10):e012062. doi:10.1136/bmjopen-2016-012062
  • Lei CC, Lee PH, Hsu YC, et al. Educational intervention in CKD retards disease progression and reduces medical costs for patients with stage 5 CKD. Ren Fail. 2013;35(1):9–16. doi:10.3109/0886022X.2012.731997
  • Shi Y, Xiong J, Chen Y, et al. The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(2):301–312. doi:10.1007/s11255-017-1679-7
  • Sabariego C, Grill E, Brach M, Fritschka E, Mahlmeister J, Stucki G. Incremental cost-effectiveness analysis of a multidisciplinary renal education program for patients with chronic renal disease. Disabil Rehabil. 2010;32(5):392–401. doi:10.3109/09638280903171584
  • Collister D, Pyne L, Cunningham J, et al. Multidisciplinary chronic kidney disease clinic practices: a scoping review. Can J Kidney Health Dis. 2019;6:2054358119882667. doi:10.1177/2054358119882667
  • Jiamjariyaporn T, Ingsathit A, Tungsanga K, et al. Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT study): rationale and design of the study [NCT01978951]. BMC Nephrol. 2014;15:99. doi:10.1186/1471-2369-15-99
  • Jiamjariyapon T, Ingsathit A, Pongpirul K, et al. Effectiveness of integrated care on delaying progression of stage 3–4 chronic kidney disease in rural communities of Thailand (ESCORT study): a cluster randomized controlled trial. BMC Nephrol. 2017;18(1):83. doi:10.1186/s12882-016-0414-4
  • Kasiske BL, Wheeler DC. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):2.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Riewpaiboon A. Standard cost lists for health economic evaluation in Thailand. J Med Assoc Thai. 2014;97(Suppl 5):S127–S134.
  • Consumer Price Index. Ministry of commerce. Available from: http://www.price.moc.go.th/price/cpi. Accessed January 30, 2020.
  • American Diabetes A. 6. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S66–S76. doi:10.2337/dc20-S006
  • Turchetti G, Bellelli S, Amato M, et al. The social cost of chronic kidney disease in Italy. Eur J Health Econ. 2017;18(7):847–858. doi:10.1007/s10198-016-0830-1
  • Srisubat A, Jiamjariyaporn T, Chanpitakkul M, et al. Cost-effectiveness of integrated care in patients with chronic kidney disease stage 3 and 4 compared with standard care in rural communities. J Depart Med Serv. 2017;42(6):54–63.
  • Provenzano M, Chiodini P, Minutolo R, et al. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics. Nephrol Dial Transplant. 2020;35(1):138–147. doi:10.1093/ndt/gfy217
  • Borrelli S, Garofalo C, Mallamaci F, et al. Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease. J Hypertens. 2018;36(12):2398–2405. doi:10.1097/HJH.0000000000001825